Yaojuan Chu

443 total citations
23 papers, 305 citations indexed

About

Yaojuan Chu is a scholar working on Molecular Biology, Neurology and Complementary and alternative medicine. According to data from OpenAlex, Yaojuan Chu has authored 23 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Neurology and 6 papers in Complementary and alternative medicine. Recurrent topics in Yaojuan Chu's work include Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Traditional Chinese Medicine Analysis (6 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Yaojuan Chu is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Traditional Chinese Medicine Analysis (6 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Yaojuan Chu collaborates with scholars based in China and United States. Yaojuan Chu's co-authors include Lin Zhu, Mengmeng Dou, Mingliang Zhang, Guang‐Xian Zhang, Mengru Wang, Xiaojian Zhang, Wendi Ma, Ying Lv, Silu Li and Xiaoyu Zhao and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Yaojuan Chu

21 papers receiving 303 citations

Peers

Yaojuan Chu
Yaojuan Chu
Citations per year, relative to Yaojuan Chu Yaojuan Chu (= 1×) peers Shiming Zhang

Countries citing papers authored by Yaojuan Chu

Since Specialization
Citations

This map shows the geographic impact of Yaojuan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaojuan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaojuan Chu more than expected).

Fields of papers citing papers by Yaojuan Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaojuan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaojuan Chu. The network helps show where Yaojuan Chu may publish in the future.

Co-authorship network of co-authors of Yaojuan Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaojuan Chu. A scholar is included among the top collaborators of Yaojuan Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaojuan Chu. Yaojuan Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Xin, Wendi Ma, Wenying Li, et al.. (2025). Oxymatrine regulates microglia to produce IFN-β by activating the STING/TBK1/IRF3 pathway against experimental autoimmune encephalomyelitis. European Journal of Pharmacology. 1009. 178380–178380.
2.
Zhang, Zhibo, Tao Yan, Liwei Liu, et al.. (2025). Comprehensive lipid metabolites-pyroptosis profiling uncovers the therapeutic efficacy of Mailuo Shutong pill against Thromboangiitis obliterans. Journal of Ethnopharmacology. 351. 120145–120145.
3.
Xu, Jing, Hongyu Zheng, Yaojuan Chu, et al.. (2025). Potential changes in microorganisms and metabolites associated with oral cancer: a preliminary study. BMC Cancer. 25(1). 611–611. 2 indexed citations
4.
Chu, Yaojuan, Xiangyu Zhang, Yingying Shi, et al.. (2024). Establishment of a multi-strategy platform for quality control and quality markers screen of Mailuoshutong pill. Journal of Pharmaceutical and Biomedical Analysis. 243. 116070–116070. 1 indexed citations
5.
Li, Xinyu, Wenbin Wang, Mengmeng Dou, et al.. (2024). Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis. Biochemical and Biophysical Research Communications. 735. 150651–150651. 4 indexed citations
6.
Dou, Mengmeng, Yaojuan Chu, Xueliang Zhou, et al.. (2023). Matrine Mediated Immune Protection in MS by Regulating Gut Microbiota and Production of SCFAs. Molecular Neurobiology. 61(1). 74–90. 6 indexed citations
8.
Chu, Yaojuan, Mengli Wang, Yingying Shi, et al.. (2022). Rapid and comprehensive identification of chemical constituents in Mai-Luo-Shu-Tong pill by UHPLC-Q-Orbitrap HRMS combined with a data mining strategy. Analytical Methods. 14(47). 4990–5000. 5 indexed citations
9.
Chu, Yaojuan, Mengmeng Dou, Xiaoyu Zhao, et al.. (2022). Matrine inhibits the Wnt3a/β-catenin/TCF7L2 signaling pathway in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 367. 577876–577876. 10 indexed citations
10.
Chu, Yaojuan, Xiangyu Zhang, Liwei Liu, et al.. (2022). Identifying quality markers of Mailuoshutong pill against thromboangiitis obliterans based on chinmedomics strategy. Phytomedicine. 104. 154313–154313. 20 indexed citations
11.
Zhang, Xiaowei, Yaojuan Chu, Yu‐Hao Li, & Xiujuan Li. (2022). Matrix compatibility of typical sol–gel solid-phase microextraction coatings in undiluted plasma and whole blood for the analysis of phthalic acid esters. Analytical and Bioanalytical Chemistry. 414(7). 2493–2503. 5 indexed citations
12.
Wang, Mengli, Xiangyu Zhang, Yaojuan Chu, et al.. (2022). Discovery of quality markers for Mailuoshutong Pill based on “spider web” mode of “Content-Pharmacokinetics-Pharmacology” network. Arabian Journal of Chemistry. 15(12). 104296–104296. 3 indexed citations
13.
Kang, Jian, Shuqing Liu, Yifan Song, et al.. (2021). Matrine treatment reduces retinal ganglion cell apoptosis in experimental optic neuritis. Scientific Reports. 11(1). 9520–9520. 12 indexed citations
14.
Chu, Yaojuan, Xiaoyu Zhao, Mengru Wang, et al.. (2021). Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 352. 577480–577480. 37 indexed citations
15.
Chu, Yaojuan, et al.. (2021). Matrine treatment induced an A2 astrocyte phenotype and protected the blood-brain barrier in CNS autoimmunity. Journal of Chemical Neuroanatomy. 117. 102004–102004. 20 indexed citations
16.
Chu, Yaojuan, Wendi Ma, Rodolfo Thomé, et al.. (2020). Matrine Inhibits CNS Autoimmunity Through an IFN-β-Dependent Mechanism. Frontiers in Immunology. 11. 569530–569530. 20 indexed citations
17.
Wang, Meng‐Ru, Xiaojian Zhang, Hongchun Liu, et al.. (2019). Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy. Brain Research Bulletin. 153. 30–38. 29 indexed citations
18.
Zhao, Xiaoyu, Xiaojian Zhang, Yuming Xu, et al.. (2016). Matrine downregulates IL-33/ST2 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis. Immunology Letters. 178. 97–104. 11 indexed citations
19.
Kan, Quancheng, Xiaojian Zhang, Yaojuan Chu, et al.. (2015). Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors. Experimental and Molecular Pathology. 99(2). 212–219. 15 indexed citations
20.
Zhu, Lin, Xiaojian Zhang, Yuming Xu, et al.. (2015). Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling. Experimental and Molecular Pathology. 100(2). 337–343. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026